A Phase 2 Clinical Trial of multi-agent Chemotherapy or letrozole plus Ribociclib (LEE011) as neoadjuvant treatment for postmenopausal patients with Luminal B/HER2-negative breast cancer
Joaquín Gavilá, MD (Fundación Valenciana de Oncología)
Aleix Prat, MD, PhD (Hospital Clínic de Barcelona)